FDA Approves New Blood Test to Identify Signs of Alzheimer’s
The Food and Drug Administration has approved a new blood test to help identify signs of Alzheimer’s disease for people 55 and older who are already showing signs of cognitive decline. The test, from pharmaceutical company Roche and partner Eli Lilly, is a bio-marker blood test.
NBC News Health
Published by CurrentWire · First coverage
Compiled by CurrentWire News Desk
Summary based on reporting from NBC News Health.
In this story
Automated coverage analysis
Generated automatically from the coverage listed on this page. CurrentWire adds no editorial claims.
All-time coverage
2 publications have covered this story since CurrentWire first saw it: The Hill, NBC News Health.
Coverage
1 publication is covering this story.
How CurrentWire compiled this story
NBC News Health (www.today.com), a Tier C publisher, filed this report on . CurrentWire published this page on .
Signal breakdown
CurrentWire ranked this story 60.2 of 100 in the snapshot this page was rendered from.
- Freshness
- 27.2 of 35
- Source authority
- 9 of 20
- Coverage breadth
- 4 of 20
- Geographic relevance
- 10 of 10
- Story prominence
- 10 of 10
- Velocity
- 0 of 5
Strongest signal: geographic relevance, 10 of 10. How each signal is calculated.
Filed under Health · United States · News. Topics extracted from this report, with other live CurrentWire stories mentioning each: FDA (2), Blood Test (none).
CurrentWire is a news discovery platform. This page summarizes and links to original reporting; full articles, imagery and copyright remain with the publishers listed above.